rs727505124
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BS1_SupportingBS2
The NM_144573.4(NEXN):c.995_997delAAG(p.Glu332del) variant causes a disruptive inframe deletion change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000639 in 1,612,878 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. E332E) has been classified as Likely benign.
Frequency
Consequence
NM_144573.4 disruptive_inframe_deletion
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NEXN | NM_144573.4 | c.995_997delAAG | p.Glu332del | disruptive_inframe_deletion | 9/13 | ENST00000334785.12 | NP_653174.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NEXN | ENST00000334785.12 | c.995_997delAAG | p.Glu332del | disruptive_inframe_deletion | 9/13 | 1 | NM_144573.4 | ENSP00000333938.7 |
Frequencies
GnomAD3 genomes AF: 0.0000395 AC: 6AN: 152028Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000106 AC: 26AN: 246126Hom.: 0 AF XY: 0.000135 AC XY: 18AN XY: 133792
GnomAD4 exome AF: 0.0000664 AC: 97AN: 1460850Hom.: 0 AF XY: 0.0000839 AC XY: 61AN XY: 726782
GnomAD4 genome AF: 0.0000395 AC: 6AN: 152028Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74258
ClinVar
Submissions by phenotype
not provided Uncertain:3
Uncertain significance, no assertion criteria provided | clinical testing | Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ | - | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | May 10, 2024 | In silico analysis supports a deleterious effect on protein structure/function; In-frame deletion of 1 amino acid in a non-repeat region; Identified in a patient with HCM in the published literature; reported as c.987_989delAGA due to the use of alternate nomenclature (PMID: 28611029); This variant is associated with the following publications: (PMID: 28611029) - |
Uncertain significance, no assertion criteria provided | clinical testing | Clinical Genetics, Academic Medical Center | - | - - |
Dilated cardiomyopathy 1CC;C3151267:Hypertrophic cardiomyopathy 20 Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 24, 2021 | This variant, c.995_997del, results in the deletion of 1 amino acid(s) of the NEXN protein (p.Glu332del), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs751883872, gnomAD 0.06%). This variant has been observed in individual(s) with cardiomyopathy (PMID: 28611029). This variant is also known as c.987_989delAGA (p.Ala329_Glu330delinsAla). ClinVar contains an entry for this variant (Variation ID: 179783). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Aug 30, 2021 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Aug 12, 2015 | The p.Glu332del variant in NEXN has been identified by our laboratory in 1 Cauca sian adult with HCM. This variant has also been identified in 12/16490 of South Asian chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadin stitute.org; dbSNP rs727505124). This variant is a deletion of 1 amino acid at p osition 332 and is not predicted to alter the protein reading-frame. It is uncle ar if this deletion will impact the protein. In summary, the clinical significan ce of the p.Glu332del variant is uncertain. - |
Cardiomyopathy Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario | Oct 13, 2017 | - - |
Cardiovascular phenotype Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 29, 2019 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at